Prenatal Diagnostics- Market Outlook & Future Endeavors

1
Prenatal Diagnostics Invasive testing,
noninvasive testing, and rising maternal
screening methods for preeclampsia and preterm
labor
Explore all reports for Diagnostics market _at_
http//www.lifescienceindustryresearch.com/catego
ry/diagnostics .
2
Prenatal Diagnostics Invasive testing,
noninvasive testing, and rising maternal
screening methods for preeclampsia and preterm
labor

• New to Insight Pharma Reports is Prenatal
  Diagnostics Invasive testing, noninvasive
  testing, and rising maternal screening methods
  for preeclampsia and preterm labor. This report
  discusses improvements in invasive procedures
  (karyotyping vs. cytogenetics), and the rise of
  noninvasive screening methods and their impact on
  prenatal healthcare. Although covering standard
  invasive procedure, this report focuses on the
  noninvasive technologies either on the market or
  in development.
• Report Highlights
• Exclusive interviews with CEOs, CSOs, and Vice
  Presidents from Sequenom, Verinata Health, Ariosa
  Diagnostics, Natera, Silicon Biosystems,
  Metabolomic

3
Prenatal Diagnostics Invasive testing,
noninvasive testing, and rising maternal
screening methods for preeclampsia and preterm
labor

• Diagnostics and NX PharmaGen
• Specifications of particular instruments
• Company goals, customer feedback, challenges
  encountered, competitive advantage, platform
  pricing, and future endeavors.
• A survey capturing the demographics of the
  prenatal industry is presented at the end of the
  report, specifically highlighting organizational
  background, areas of research, challenges
  encountered, and applications in development.
• Directory of companies within Prenatal
  Diagnostics

4
Prenatal Diagnostics Invasive testing,
noninvasive testing, and rising maternal
screening methods for preeclampsia and preterm
labor
Executive Summary New to insight Pharma Reports
is Prenatal Diagnostics Invasive testing,
noninvasive testing, and rising maternal
screening methods for preeclampsia and preterm
labor. This report discusses improvements in
invasive procedures (karyotyping vs.
cytogenetics), and the rise of noninvasive
screening methods and their impact on prenatal
healthcare. Although covering standard invasive
procedure, this report focuses on the noninvasive
technologies either on the market or in
development.
5
Prenatal Diagnostics Invasive testing,
noninvasive testing, and rising maternal
screening methods for preeclampsia and preterm
labor
The first chapter of this report discusses
microarray-based cytogenetics and how it compares
to karyotyping. Karyotyping is often the standard
method used to detect chromosomal aneuploidies,
but with microarray-based procedures even more
aneuploidies can be detected with the same
efficacy. Either method can be used in sync with
noninvasive procedures that show positive
screening results for aneuploidies, but
microarray analysis may be more useful for copy
number variations that often go undetected with
karyotyping.
6
Prenatal Diagnostics Invasive testing,
noninvasive testing, and rising maternal
screening methods for preeclampsia and preterm
labor
Highlighting noninvasive methods, several
companies have come out with novel technologies
that allow them to analyze fetal DNA without risk
of injury to the mother or fetus. Amniocentesis
and chorionic villus sampling are common methods
used to analyze fetal DNA for aneuploidies but at
the risk of miscarriage and infection. With
noninvasive procedures, screening can be done for
common aneuploidies and further analysis can be
done on women with only positive results
7
About lifescienceindustryresearch.com
lifescienceindustryresearch.com is your single
source for all market research needs. Our
database includes 250,000 syndicated market
research reports from 100 leading global
publishers covering in-depth analysis of over
5000 micro markets. With comprehensive
information about the publishers and their report
methodology, data sources, etc. we help you in
your purchase decision by mapping your
information needs with the most relevant
available reports in our library.
Connect with us sales_at_lifescienceindustryresearc
h.com 1 888 391 5441 Contact http//www.lifes
cienceindustryresearch.com  for further
information.
Contact sales_at_reportsandreports.com for further
information.